Literature DB >> 7096214

Minimal concentrations of metabolic substrates capable of supporting cochlear potentials.

J Kambayashi, T Kobayashi, N Y Marcus, J E DeMott, I Thalmann, R Thalmann.   

Abstract

The objective of this study was to determine the capability of glucose analogues, as well as lactate and pyruvate, to maintain the endolymphatic potential and the cochlear microphonics. In addition, the minimum concentration at which different substrates (including D-glucose) were able to sustain the potentials ("critical' concentration) was determined. Synthetic blood containing various substrates at different concentrations was perfused via the anterior inferior cerebellar artery. The critical concentration for D-glucose was found to be 15 mg% (0.83 mM). L-Glucose, galactose and fructose were not able to support the potentials at concentrations as high as 200 mg%. On the other hand, mannose was capable of supporting the potentials; however, the critical concentration (50 mg% or 2.8 mM) was substantially higher than that of D-glucose. Both lactate and pyruvate could support the potentials, but the critical concentrations (8.5 mM and 6.5 mM, respectively) were markedly higher than in the case of glucose, even when the difference of carbon equivalents was taken into consideration. The data are discussed in the context of the intermediary metabolism and possible carrier systems of the stria vascularis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096214     DOI: 10.1016/0378-5955(82)90084-3

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  2 in total

1.  Prolonged maintenance of endocochlear potential by vascular perfusion with media devoid of oxygen carriers.

Authors:  T Kobayashi; M Rokugo; D C Marcus; T H Comegys; R Thalmann
Journal:  Arch Otorhinolaryngol       Date:  1984

Review 2.  Diabetes and Auditory-Vestibular Pathology.

Authors:  Saravanan Elangovan; Christopher Spankovich
Journal:  Semin Hear       Date:  2019-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.